MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 161 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $15,739,000 | -56.9% | 73,500 | -43.7% | 0.00% | -50.0% |
| Q2 2018 | $36,500,000 | +448.3% | 130,500 | +128.9% | 0.01% | +700.0% |
| Q1 2018 | $6,657,000 | -0.6% | 57,000 | -86.9% | 0.00% | -50.0% |
| Q1 2017 | $6,699,000 | +3.3% | 435,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $6,482,000 | – | 435,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
| Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
| ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
| Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
| Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
| Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
| Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
| EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
| DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |